Literature DB >> 3196024

Analysis of the secondary structure of hirudin and the mechanism of its interaction with thrombin.

S Konno1, J W Fenton, G B Villanueva.   

Abstract

Highly purified hirudin with a specific activity of 13,950 antithrombin units/mg was isolated from a commercial preparation by reversed-phase chromatography. The circular dichroism (CD) spectrum of hirudin was investigated and it was found that the spectrum cannot be accounted for solely in terms of the traditional three components of peptide backbone. It was also found that the CD spectrum of the thrombin-hirudin complex was not additive with respect to the individual spectra of thrombin and hirudin. This deviation from additivity was significant between 210 and 225 nm, indicating alterations in the secondary structures of the proteins during complex formation. When thrombin was titrated with hirudin, the spectral deviation from additivity was sigmoidal, suggesting the cooperative nature of the binding process. Gel filtration of the thrombin-hirudin mixture showed no molecular species greater than a 1:1 complex (Mr 45,500), but gel filtration of free hirudin showed a multimeric form (Mr 51,300) under the same experimental conditions. It is concluded that the cooperative nature of the binding process is due to the binding of thrombin molecules to the multimeric form of hirudin. This initial binding occurs with little or no change in the CD spectrum. In the second step, the multiple complex dissociates to form 1:1 complexes, resulting in larger conformational changes and a considerable increase in binding affinity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3196024     DOI: 10.1016/0003-9861(88)90019-7

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

Review 1.  Hirudin, a new therapeutic tool?

Authors:  J Bichler; H Fritz
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

2.  The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the Tyr-Pro-Pro-Trp segment and active site residues upon ligand binding.

Authors:  M G Malkowski; P D Martin; J C Guzik; B F Edwards
Journal:  Protein Sci       Date:  1997-07       Impact factor: 6.725

3.  State of aggregation of recombinant hirudin in solution under physiological conditions.

Authors:  T W Thannhauser; H A Scheraga
Journal:  J Protein Chem       Date:  1996-11

Review 4.  Hirudin-based anticoagulant strategies for patients with suspected heparin-induced thrombocytopenia undergoing percutaneous coronary interventions and bypass grafting.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

5.  Hirudin: Its Biology and Clinical Use.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.